Epidemiological Surveillance Reveals the Rise and Establishment of the Omicron SARS-CoV-2 Variant in Brazil.
Joice do Prado SilvaAline Brito de LimaLuige Biciati AlvimFrederico Scott Varella MaltaCristiane Pinheiro Toscano Brito MendonçaAndré Henrique Barbosa de CarvalhoJéssica Silqueira Hickson RiosPaula Luize Camargos FonsecaDaniel Costa QueirozLuíza Campos Guerra de Araújo E SantosAlessandro Clayton de Souza FerreiraRenan Pedra de SouzaRenato Santana de AguiarDanielle Alves Gomes ZauliPublished in: Viruses (2023)
The introduction of SARS-CoV-2 variants of concern (VOCs) in Brazil has been associated with major impacts on the epidemiological and public health scenario. In this study, 291,571 samples were investigated for SARS-CoV-2 variants from August 2021 to March 2022 (the highest peak of positive cases) in four geographical regions of Brazil. To identify the frequency, introduction, and dispersion of SARS-CoV-2 variants in 12 Brazilian capitals, VOCs defining spike mutations were identified in 35,735 samples through genotyping and viral genome sequencing. Omicron VOC was detected in late November 2021 and replaced the Delta VOC in approximately 3.5 weeks. We estimated viral load differences between SARS-CoV-2 Delta and Omicron through the evaluation of the RT-qPCR cycle threshold (Ct) score in 77,262 samples. The analysis demonstrated that the Omicron VOC has a lower viral load in infected patients than the Delta VOC. Analyses of clinical outcomes in 17,586 patients across the country indicated that individuals infected with Omicron were less likely to need ventilatory support. The results of our study reinforce the importance of surveillance programs at the national level and showed the introduction and faster dispersion of Omicron over Delta VOC in Brazil without increasing the numbers of severe cases of COVID-19.
Keyphrases
- sars cov
- public health
- respiratory syndrome coronavirus
- copy number
- end stage renal disease
- chronic kidney disease
- ejection fraction
- computed tomography
- magnetic resonance imaging
- genome wide
- newly diagnosed
- image quality
- mass spectrometry
- coronavirus disease
- contrast enhanced
- gene expression
- patient reported outcomes
- high resolution
- quality improvement
- drug induced